Draftkings Inc. diskutieren
DraftKings (DKNG) had its "outperform" rating reaffirmed by Sanford C. Bernstein.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its "buy" rating reaffirmed by Benchmark Co..
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its "buy" rating reaffirmed by Guggenheim.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) was given a new $31.00 price target by Susquehanna. They now have a "positive" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its price target raised by TD Cowen from $30.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its price target raised by JPMorgan Chase & Co. from $31.00 to $34.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its price target lowered by Wells Fargo & Company from $32.00 to $29.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its "buy" rating reaffirmed by Benchmark Co..
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its price target lowered by Truist Financial Corporation from $30.00 to $29.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its price target lowered by Morgan Stanley from $39.00 to $36.00. They now have an "overweight" rating on the stock.
Ratings data for DKNG provided by MarketBeat
DraftKings (DKNG) had its price target raised by Benchmark Co. from $29.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for DKNG provided by MarketBeat
Neueste Beiträge
StockNews_com in Heron Therapeutics Inc. diskutieren